Mesoblast (MESO) Exchange Rate Effect (2016 - 2021)
Mesoblast's (MESO) quarterly Exchange Rate Effect came in at $75000.0 in Q4 2021, down 93.4% year-on-year from $1.1 million in Q4 2020, and up 115.72% quarter-over-quarter from -$477000.0 in Q3 2021.
Mesoblast (MESO) Exchange Rate Effect (2016 - 2021) Analysis & Trends
Mesoblast has disclosed Exchange Rate Effect across 5 years of filings, most recently posting $75000.0 for Q4 2021.
- Exchange Rate Effect for Q4 2021 came in at $75000.0, down 93.4% year-over-year; the trailing twelve-month figure through Dec 2021 was $1.2 million (down 8.86% YoY), and the FY2025 annual result was $1.1 million, up 2080.0% from the prior year.
- Exchange Rate Effect came in at $75000.0 for Q4 2021 at Mesoblast, up from -$477000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q4 2020 to a low of -$477000.0 in Q3 2021.
- The 4-year median for Exchange Rate Effect is -$35000.0 (2017), against an average of $101181.8.
- Across the five-year window, Exchange Rate Effect jumped 96.02% in 2017 and sank 297.14% in 2018, its largest moves.
- Mesoblast's Exchange Rate Effect stood at -$117000.0 in 2017, then fell by 22.22% to -$143000.0 in 2018, then surged by 894.41% to $1.1 million in 2020, then plunged by 93.4% to $75000.0 in 2021.
- The last three Exchange Rate Effect figures came in at $75000.0 (Q4 2021), -$477000.0 (Q3 2021), and $1.1 million (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 75,000.00 |
| Dec 31, 2021 | 75,000.00 |
| Sep 30, 2021 | -477,000.00 |
| Sep 30, 2021 | -477,000.00 |
| Dec 31, 2020 | 1.14 Mn |
| Dec 31, 2020 | 1.14 Mn |
| Sep 30, 2020 | 501,000.00 |
| Sep 30, 2020 | 501,000.00 |
| Sep 30, 2018 | -143,000.00 |
| Sep 30, 2018 | -143,000.00 |
| Jun 30, 2018 | -139,000.00 |
| Jun 30, 2018 | -139,000.00 |
| Mar 31, 2018 | 96,000.00 |
| Mar 31, 2018 | 96,000.00 |
| Dec 31, 2017 | -117,000.00 |
| Dec 31, 2017 | -117,000.00 |
| Sep 30, 2017 | -286,000.00 |
| Sep 30, 2017 | -286,000.00 |
| Jun 30, 2017 | -35,000.00 |
| Jun 30, 2017 | -35,000.00 |